"A CONTROLLED, ASSESSOR-BLIND, PARALLEL GROUPS, MULTICENTRE, MULTINATIONAL TRIAL EVALUATING THE IMMUNOGENICITY OF FE 999049 IN REPEATED CYCLES OF CONTROLLED OVARIAN STIMULATION IN WOMEN UNDERGOING AN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMME. ESTHER-2 (EVIDENCE-BASED STIMULATION TRIAL AND HUMAN RFSH IN EUROPE AND REST OF THE WORLD)

Registry ID

000071 (ESTHER-2)

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

FERRING INC

Start date

2014-03-01

Completion date

2016-10-12

Last update

2013-09-20

Conditions

• ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMME
• OVARIAN STIMULATION

Related clinical trials

• Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity
• Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?
• RESCUE PROGESTERONE SUPPLEMENTATION IN PATIENTS WITH LOW PROGESTERONE ON THE DAY OF EMBRYO TRANSFER FOR MODIFIED NATURAL CYCLES: A NON-INFERIORITY STUDY

View on source registry